Obesity Trial, Recruiting NCT07372729 Sponsor: Beijing Anzhen Hospital Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07372729
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older, of any gender
  • People who are overweight or obese, defined as having a Body Mass Index (BMI) between 24.0 and 32.4, or a waist measurement of 90 cm or more (men) or 85 cm or more (women)
  • People who have at least one of the following borderline health conditions, but have not been formally diagnosed with high blood pressure, diabetes, or a cholesterol disorder: slightly elevated blood pressure (top number 130–139 and/or bottom number 80–89 mmHg) without blood pressure medication in the past month; slightly elevated blood sugar levels or a borderline HbA1c result, without diabetes medication in the past month; or slightly elevated cholesterol or triglyceride levels, without cholesterol-lowering medication in the past month
  • People who live permanently in the local area and expect to remain there for at least 12 months after joining
  • People who are able to read, write, and understand basic information, can use a smartphone connected to the internet, and can operate a mobile app independently
  • People who are willing and able to provide written consent to participate

Who may not be able to join:

  • People whose obesity has been diagnosed by a doctor as being caused by another medical condition (secondary obesity)
  • People with a history of heart or stroke-related conditions, such as heart attack, stroke, heart failure, or irregular heartbeat, or who have had heart surgery or a procedure on their coronary arteries, or who are assessed as being at high risk of a cardiovascular event within 10 years
  • People with a serious illness that significantly affects life expectancy, such as cancer, AIDS, or severe liver or kidney failure
  • People who are pregnant, breastfeeding, or who may become pregnant within the next year
  • People with a history of severe mental health or neurological conditions that may affect thinking or communication, such as dementia, Alzheimer's disease, or Parkinson's syndrome
  • People with significant limitations in their ability to move around in daily life
  • People who are currently using, or planning to use, surgery, medication, or other methods specifically for weight loss
  • People who are currently taking part in another trial focused on lifestyle changes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: yue qi, PhD, Beijing Anzhen Hospital

Phone: 01081997731

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Anzhen Hospital
Registry
ClinicalTrials.gov
Start date
24 March 2026
Est. completion
24 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in Life's Essential 8 risk score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov